AI Takeaway
Accenture delivered solid Q3 FY2026 results with revenue of $18.7B (+5.6% YoY), operating income of $3.2B (+6.5% YoY), and diluted EPS of $3.80 (+8.9% YoY), reflecting steady demand for consulting and managed services alongside strong year-to-date operating cash flow of $9.3B.
Revenue
$18.72B
++5.59% YoY
EPS (Basic)
$3.82
++8.52% YoY
Operating Income
$3.18B
++6.45% YoY
Filed · Analysis updated · Source: SEC EDGAR 10-Q filing
ACN reported Q3 FY2026 revenue of $18.72B, up 5.6% year-over-year from $17.73B, indicating continued client investment in technology and consulting services across its global business segments.
Source: Source: 10-Q Income Statement (XBRL Financial Data)
Operating margin improved slightly to 16.96% from 16.83% in the prior-year period, suggesting Accenture is maintaining cost discipline even as cost of revenue grew 5.7% YoY to $12.58B, roughly in line with revenue growth.
Source: Source: 10-Q Income Statement & Key Ratios (XBRL Financial Data)
Cumulative fiscal year-to-date operating cash flow reached $9.27B, a robust 22.6% increase versus the prior-year same period of $7.56B, reflecting improved working capital management and earnings quality.
Source: Source: 10-Q Cash Flow Statement (XBRL Financial Data)
2 more insights available
Upgrade to unlockCurrent liabilities increased 15.1% YoY to $21.61B, significantly outpacing the 5.6% growth in current assets ($28.94B), bringing the current ratio down to 1.34. While still above 1.0, continued divergence could tighten near-term liquidity headroom.
Source: Source: 10-Q Balance Sheet (XBRL Financial Data)
Unlock 4 more detailed risk analysis
Upgrade to unlockReported EPS of $3.80 versus the $3.75 analyst consensus — a +1.4% beat for Q3 FY2026.
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $18.72B | $17.73B | +5.59% |
Cost of Revenue | $12.58B | $11.9B | +5.74% |
Operating Income | $3.18B | $2.98B | +6.45% |
Net Income | $2.34B | $2.2B | +6.44% |
EPS (Basic) | $3.82 | $3.52 | +8.52% |
EPS (Diluted) | $3.80 | $3.49 | +8.88% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $68.81B | $63.36B | +8.59% |
Current Assets | $28.94B | $27.42B | +5.55% |
Current Liabilities | $21.61B | $18.77B | +15.13% |
Stockholders' Equity | $31.89B | $30.55B | +4.37% |
Cash & Equivalents | $10.17B | $9.63B | +5.54% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash FlowYTD | $9.27B | $7.56B | +22.59% |
Investing Cash FlowYTD | $-3.45B | $-1.25B | -176.55% |
Financing Cash FlowYTD | $-7.09B | $-1.67B | -323.76% |
Share BuybacksYTD | $5.19B | $4.15B | +25.27% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 17.0% | 16.8% | +0.14% |
Net Margin | 12.5% | — | — |
ROE | 7.3% | — | — |
ROA | 3.4% | — | — |
Current Ratio | $1.339 | — | — |
Other companies in IT Consulting & Other Services
Accenture reported Q3 FY2026 revenue of $18.72B (+5.6% YoY) and diluted EPS of $3.80 (+8.9% YoY), with operating income rising 6.5% to $3.18B. The results reflect steady demand across its consulting and managed services businesses with modest margin expansion.
The key takeaways are consistent revenue and earnings growth, a slight improvement in operating margin to 16.96%, and exceptionally strong year-to-date operating cash flow of $9.27B (+22.6% YoY). Accenture also accelerated share buybacks to $5.19B YTD, boosting per-share earnings growth above net income growth.
Accenture's revenue grew 5.6% year-over-year to $18.72B in Q3 FY2026, up from $17.73B in the same quarter of the prior fiscal year. This growth reflects continued client investment in digital transformation, AI, and outsourcing services.
Based on the financial data, key risks include current liabilities growing 15.1% YoY to $21.61B (outpacing current asset growth), a dramatic increase in investing and financing cash outflows, and cost of revenue growing nearly as fast as revenue, limiting gross margin expansion. No filing text was available to identify additional management-disclosed risks.
Accenture's financial health appears solid: total assets of $68.81B, stockholders' equity of $31.89B, cash of $10.17B, and a current ratio of 1.34 all point to a well-capitalized company. However, the 15.1% surge in current liabilities and large financing outflows from buybacks are worth monitoring for liquidity management going forward.